Zaia JA, Hawkins, G.  Protein Kinase Deficient, Immunologically Active CMVpp65 Mutants.  U.S. Patent 7,025,969 April 11, 2006

Zaia JA, Hawkins, G.  Protein Kinase Deficient, Immunologically Active CMVpp65 Mutants.  U.S. Patent 6,835,383 December 28, 2004

Zaia JA, Giugni, TD, Moller E, Soderberg C.  Treatment of cytomegalovirus using aminopeptidase N.  U.S. Patent 6,511,662 January 28, 2003

Pande H, Riggs A, Zaia JA, Clark B.  Method for Detection and Prevention of Human Cytomegalovirus Infection.  U.S. Patent 6,242,567 June 5, 2001

Pande H, Zaia JA.  Induction of Cytolytic T-Lymphocytes with Cytomegalovirus Polypeptides.  U.S. Patent 6,207,161 March 27, 2001

Pande H, Riggs A, Zaia JA, Clark B.  Method for Detection and Prevention of Human Cytomegalovirus Infection.  U.S. Patent 6,133,433 October17, 2000

Rossi JJ, Cantin EM, Zaia JA, Chang P.  Ribozyme Cleavage of HIV-RNA.  U.S. Patent 6,069,007, May 30, 2000

Rossi JJ, Cantin EM, Zaia JA, Chang P.  Ribozyme Cleavage of HIV-I-RNA.  U.S. Patent 5,144,019, September 1, 1992

Cantin EM, Zaia JA, Wallace RB, Rossi JJ.  Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates.  U.S. Patent 5,110,802, May 5, 1992

Pande H, Riggs AD, Zaia JA.  Method for detection and prevention of human cytomegalovirus infection.  U.S. Patent 5,075,213, December 24, 1991